Advocacy groups express unease about potential changes to the parity rule, indicating future involvement in rulemaking.
Following what advocates are calling an unsurprising but disappointing announcement that the Trump administration intends to rewrite a parity final rule that is being challenged in federal court, the substance use advocacy community is positioning for involvement in a new rulemaking process. However, it remains uncertain as to how such a process might unfold, given the unusual circumstances around the possible revision of a federal rule without the presence of any new legislation.
No takes yet. Share an insight, caveat, or question.
Gary Enos (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: